In our study, we observed that the expression of CXCR3 was up‐regulated in cluster 4 (mainly from tumours of patients with Notch pathway mutations) compared with cluster 0 (mainly from tumours of non‐mutation patients) of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.